Drugmakers Share Confidential Data to Aid in Olympic Drug Tests

Some of the world's largest drug manufacturers are playing a larger role in anti-doping efforts at the 2014 Winter Olympics. They're providing information on drugs that once would have been considered proprietary trade secrets. GlaxoSmithKline, Amgen and Roche are among the companies that have begun sharing "confidential research and data" with anti-doping officials about experimental drugs they are developing. Read the full story